Surgical Treatment for the Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children
NCT ID: NCT03447496
Last Updated: 2018-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2018-01-01
2018-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Type II Pediatric Supracondylar Humerus Fracture Management and Outcomes: A Prospective Multi-centre Cohort Study
NCT02963233
Multi-center Study on Surgical or Non-surgical Treatment for Children Type 1 Humeral Condyle Fracture
NCT02773511
ORIF Versus CRIF of Completely Displaced and Rotated Lateral Condylar Fractures of the Humerus in Children
NCT04640727
Treatment of Displaced Medial Epicondyle Fractures In Children
NCT06454929
Pediatric Type III Supracondylar Humeral Fracture
NCT04780308
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Closed reduction
The children were treated with closed reduction.
Closed reduction
The children were treated with closed reduction.
Open reduction
The children were treated with open reduction.
Open reduction
The children were treated with Open reduction.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Closed reduction
The children were treated with closed reduction.
Open reduction
The children were treated with Open reduction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shunyou Chen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shunyou Chen
Director,Head of Orthopaedics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chen Shunyou, Phd
Role: STUDY_DIRECTOR
The Fuzhou No 2 Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shunyou Chen
Fuzhou, Fujian, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Shunyou Chen
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.